What are the contributing causes of polypharmacy in older adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Polypharmacy in older adults is primarily caused by multiple chronic conditions requiring different medications, varied symptoms and complaints associated with these conditions, and factors such as multiple prescribers and pharmacies, which can lead to polyproviders and patient stockpiling of medications. The most recent and highest quality study, 1, highlights that advanced age, female sex, multiple chronic medical conditions, cognitive impairment, low body weight, creatinine clearance less than 50 mL/min, frailty, lack of medical knowledge, multiple prescribers and pharmacies, and the concurrent use of 9 or more medications can increase the risk of an adverse drug event (ADE) due to polypharmacy. Some of the key contributing causes of polypharmacy in older adults include:

  • Varied symptoms and complaints associated with multiple chronic illnesses
  • Polyproviders, which can lead to a lack of coordination in care and increased medication use
  • Patient stockpiling of medications, which can occur due to a lack of understanding of their medication regimen or fear of running out of medications
  • Self-prescribing over-the-counter medications by patients, not providers, which can also contribute to polypharmacy, although this is not directly addressed in the provided studies. It is essential to consider these factors when managing polypharmacy in older adults, as they can have a significant impact on the patient's quality of life, morbidity, and mortality, as noted in 1. The use of guidelines such as Beers and STOPP/START criteria, as mentioned in 1, can help recognize high-risk medications in older adults and avert adverse drug events. Overall, a comprehensive assessment and deprescribing plan are crucial in managing polypharmacy in older patients, as highlighted in 1 and 1.

From the Research

Contributing Causes of Polypharmacy in Older Adults

The following are contributing causes of polypharmacy in older adults:

  • Varied symptoms and complaints associated with multiple chronic illnesses 2, 3, 4, 5, 6
  • Patient-related factors, including having multiple medical conditions managed by multiple subspecialist physicians, having chronic mental health conditions, and residing in a long-term care facility 3
  • Systems-level factors, including poorly updated medical records, automated refill services, and prescribing to meet disease-specific quality metrics 3
  • Polyproviders, as individual physicians varied in their prescribing practices, even after adjusting for patient demographic and clinical characteristics 5
  • Patient stockpiling of medications is not directly mentioned in the studies as a contributing cause, but patient factors such as female sex, higher BMI, having Medicaid insurance, current or former smoking status, comorbidities, and seeing a specialist were associated with the number of medications 5
  • Self-prescribing over-the-counter medications by providers is not mentioned in the studies, but patients taking multiple medications, including over-the-counter medications, can increase the risk of adverse medical outcomes 3, 4, 6

Related Questions

What is polypharmacy (the use of multiple medications) and its implications on prescribing practices?
What is the most efficient way to manage a Frailty Assessment Unit with 6 chairs and a Short Stay Unit with 26 beds in the National Health Service (NHS) according to worldwide recommendations?
Can cyclizine and ondansetron be taken together?
What are the significant contraindications between furosemide (Lasix) 20mg, metoprolol succinate (Extended-Release Metoprolol) 50mg, losartan (Cozaar) 25mg, dapagliflozin (Farxiga) 10mg, bupropion (Wellbutrin) hydrochloride 150mg, rosuvastatin (Crestor) 20mg, apixaban (Eliquis) 5mg, tolterodine (Detrol) extended-release 4mg, omega-3 fatty acids (Fish Oil) 1200mg, ascorbic acid (Vitamin C) 500mg, vitamin B complex 50mg, calcium with vitamin D and minerals, and garlic supplements?
What is the appropriate intervention for a patient at risk of oversedation due to polypharmacy including benzodiazepines (benzos), opioids, and Z-drugs?
What is the treatment for plantar fasciitis?
What is the most appropriate first-line symptom-directed therapy for mild symptoms of alcohol withdrawal in an elderly patient?
Is aspirin indicated for primary prevention of cardiovascular events in a 65-year-old woman with pre-diabetes (impaired glucose regulation) and hypercholesterolemia (elevated cholesterol)?
What is the recommended dose of doxycycline (Doxycycline) for treating chlamydia?
What are the risks for a patient who received a total of 187.5mg of Solumedrol (methylprednisolone) intravenously (IV), with the last dose administered 15 hours ago?
What is an appropriate hemoglobin (Hb) A1c goal for an older adult patient with moderate comorbidity and a limited life expectancy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.